Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells
- PMID: 22850801
- DOI: 10.1007/s10120-012-0166-1
Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells
Abstract
Background: Mesenchymal stem cells (MSCs) have the ability to migrate into tumors and therefore are potential vehicles for the therapy of malignant diseases. In this study, we investigated the use of umbilical cord blood mesenchymal stem cells (UCB-MSCs) as carriers for a constant source of transgenic LIGHT (TNFSF14) to target tumor cells in vivo.
Methods: Lentiviral vectors carrying LIGHT genes were constructed, producing viral particles with a titer of 2 × 10(8) TU/L. Fourteen days after UCB-MSCs transfected by LIGHT gene packaged lentivirus had been injected into mouse gastric cancer models, the expression levels of LIGHT mRNA and protein were detected by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Then the tumors' approximate volumes were measured.
Results: The treatment with MSC-LIGHT demonstrated a strong suppressive effect on tumor growth compared to treatment with MSC and NaCl (p < 0.001). Examination of pathological sections of the tumor tissues showed that the areas of tumor necrocis in the MSC-LIGHT group were larger than those in the MSC group. Moreover, we found that MSCs with LIGHT were able to significantly induce apoptosis of tumor cells. The expression levels of LIGHT mRNA and protein were significantly higher in the UCB-MSCs with the LIGHT gene than the levels in UCB-MSCs (p < 0.001).
Conclusion: These results suggest that UCB-MSCs carrying the LIGHT gene have the potential to be used as effective delivery vehicles in the treatment of gastric cancers.
Similar articles
-
[Study of inhibiting and killing effects of transgenic LIGHT human umbilical cord blood mesenchymal stem cells on stomach cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Nov;15(11):1178-81. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 23172534 Chinese.
-
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.Hum Gene Ther. 2019 Jul;30(7):906-917. doi: 10.1089/hum.2018.054. Epub 2019 Apr 22. Hum Gene Ther. 2019. PMID: 30773946 Free PMC article.
-
Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451. Cancer Res. 2008. PMID: 19047138
-
Mesenchymal stem cells and their potential therapeutic benefits and challenges in the treatment and pathogenesis of gastric cancer.Pathol Res Pract. 2024 Aug;260:155422. doi: 10.1016/j.prp.2024.155422. Epub 2024 Jun 26. Pathol Res Pract. 2024. PMID: 38981347 Review.
-
Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells.Int J Mol Sci. 2024 Jul 16;25(14):7791. doi: 10.3390/ijms25147791. Int J Mol Sci. 2024. PMID: 39063032 Free PMC article. Review.
Cited by
-
Interplay between mesenchymal stem cell and tumor and potential application.Hum Cell. 2020 Jul;33(3):444-458. doi: 10.1007/s13577-020-00369-z. Epub 2020 May 6. Hum Cell. 2020. PMID: 32378164 Review.
-
Gastric cancer stem cells: a novel therapeutic target.Cancer Lett. 2013 Sep 10;338(1):110-9. doi: 10.1016/j.canlet.2013.03.035. Epub 2013 Apr 10. Cancer Lett. 2013. PMID: 23583679 Free PMC article. Review.
-
Hepatic stellate cell mediates transcription of TNFSF14 in hepatocellular carcinoma cells via H2S/CSE-JNK/JunB signaling pathway.Cell Death Dis. 2022 Mar 15;13(3):238. doi: 10.1038/s41419-022-04678-z. Cell Death Dis. 2022. Retraction in: Cell Death Dis. 2022 Nov 30;13(12):1012. doi: 10.1038/s41419-022-05464-7. PMID: 35292636 Free PMC article. Retracted.
-
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.J Biomed Sci. 2021 Apr 14;28(1):28. doi: 10.1186/s12929-021-00725-7. J Biomed Sci. 2021. PMID: 33849537 Free PMC article. Review.
-
Mesenchymal Stem Cells in Gastric Cancer: Vicious but Hopeful.Front Oncol. 2021 May 11;11:617677. doi: 10.3389/fonc.2021.617677. eCollection 2021. Front Oncol. 2021. PMID: 34046337 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical